Intervention

No Drug

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions4

Lead sponsors shown3

Clinical trials

3 shown

Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered NSCLCNCT07516015 · 2026-04-10

NOT_YET_RECRUITING

Immune System Effects in Children Born to Women With Multiple Sclerosis Treated With Monoclonal Antibody Therapy During PregnancyNCT07149662 · 2026-02-01

NOT_YET_RECRUITING

PP13 and Doppler Study to Predict PreeclampsiaNCT00928213 · 2009-08-01

Common conditions

Multiple Sclerosis1 NSCLC1 Preeclampsia1 Pregnancy1

Leading sponsors

Ben-Gurion University of the Negev1 Nanjing Tianyinshan Hospital1 Region Stockholm1

Trial status mix

NOT_YET_RECRUITING2

UNKNOWN1

Phase mix

PHASE21

PHASE31

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.